1 year return (CAGR)
-14.74%
NewAmsterdam Pharma Company N.V. Ordinary Shares Exchange (NASDAQ, USD)
NAMS
22.74
+0.06 (+0.26%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
31.94%
5 year return (CAGR)
18.50%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.66B
Price/Sales
373.32
Ent value
2.31B
Price/Book
4.21
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 22.47 |
| Daily high | 23.19 |
| Daily low | 21.95 |
| Daily Volume | 1.82M |
| All-time high | 41.45 |
| 1y analyst estimate | 51.68 |
| Beta | 0.09 |
| EPS (TTM) | -2.10 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NAMS | S&P500 | |
| Current price drop from All-time high | -45.14% | -1.38% |
| Highest price drop | -66.23% | -56.47% |
| Date of highest drop | 25 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -17.95% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 459 days | 1805 days |
News
